Retatrutide will likely still have the low chance of severe issues like: Acute pancreatitis Gallbladder problems Severe GI events Potential for Allergic reactions A warning about thyroid tumors: No cases of medullary thyroid cancer or C-cell hyperplasia were reported in retatrutide trials, but GLP-1 receptor agonists as a class carry preclinical warnings based on rodent studies
It is often marketed for skin whitening, but its real role is as an antioxidant
References: Seiwerth, S., Milavi, M., Vukojevi, J., Gojkovi, S., Krezic, I., Batelja Vuleti, L., Horvat Pavlov, K., Petrovic, A., Sikiric, S., Vranes, H., Prtoric, A., Zizek, H., Durasin, T., Dobric, I., Knezevic, M., Sola, M., Kokot, A., Sever, M., Lovric, E., Skrtic, A., Boban Blagaic, A., & Sikiric, P
Diabetes Care 36 , 10671073 (2013)
Always discuss with your healthcare provider about timing and protective measures to avoid adverse effects from this combination
Khunti, Expert panel guidance and narrative review of treatment simplification of complex insulin regimens to improve outcomes in type 2 diabetes